Cystic fibrosis therapies will push Vertex ahead of GSK in $46.6 billion respiratory market by 2022: GBI

Read more

GST is likely to bring down total cost as a percentage of sales by 1 – 1.5%

Read more

IPM crosses Rs 10,000-crore mark in July 2016

Read more

TPP likely to have serious implications for pharma industry: Study

Read more

DRL launches Bupropion HCl extended-release tabs in the US

Read more

Global pharmacy awards go to pharmacists in seven countries

Read more

UBM conducts workshop on unannounced audits in Mumbai

Read more

Cipla receives final approval for generic Enablex tablets

Read more

Aptar Pharma signs development and license agreement with BD

Read more

EXIM Bank releases study on Indian pharma industry

Read more